Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer ; volume:23 ; number:1 ; day:17 ; month:4 ; year:2023 ; pages:1-10 ; date:12.2023
BMC cancer ; 23, Heft 1 (17.4.2023), 1-10, 12.2023
- Creator
-
Li, Jieqing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10774-w
- URN
-
urn:nbn:de:101:1-2023082911142202189313
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Jieqing
- SpringerLink (Online service)
Other Objects (12)
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Hypoxia enhances autophagy level of human sperms
Cytotoxicity of doxorubicin conjugated with C60 fullerene. Structural and in vitro studies
2DG enhances the susceptibility of breast cancer cells to doxorubicin
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Hypoxia enhances autophagy level of human sperms
Cytotoxicity of doxorubicin conjugated with C60 fullerene. Structural and in vitro studies
2DG enhances the susceptibility of breast cancer cells to doxorubicin
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Hypoxia enhances autophagy level of human sperms
Cytotoxicity of doxorubicin conjugated with C60 fullerene. Structural and in vitro studies
2DG enhances the susceptibility of breast cancer cells to doxorubicin